Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 30)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
23-Nov-09 Thomson StreetEvents N/A CMED - Event Transcript of China Medical Technologies, Inc. conference call, Nov. 19, 2009 / 8:00am ET 13 $75 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR 5 $25 View Abstract
17-Nov-09 Institutional Shareholder Services N/A ISS Report on China Medical Technologies Inc. 9 $100 View Abstract
16-Nov-09 Institutional Shareholder Services N/A ISS Report on China Medical Technologies Inc. 8 $100 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR 5 $25 View Abstract
8-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR 5 $25 View Abstract
8-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR 5 $25 View Abstract
5-Nov-09 Global Markets Direct Global Markets Direct China Medical Technologies, Inc. - medical equipment - Deals and Alliances Profile 37 $250 View Abstract
4-Nov-09 Global Markets Direct Global Markets Direct China Medical Technologies, Inc. Financial Analysis Review 34 $300 View Abstract
2-Nov-09 Graham & Whiteside Limited Graham & Whiteside PEOPLE'S REPUBLIC OF CHINA - Public BIOTECHNOLOGY Companies - Graham & Whiteside listing 9 $100 View Abstract
Next 20

Brokerage Reports (Showing 1 to 3 of 3)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
23-Nov-09 Thomson StreetEvents N/A CMED - Event Transcript of China Medical Technologies, Inc. conference call, Nov. 19, 2009 / 8:00am ET 13 $75 View Abstract
20-Mar-09 Brean Murray & Co., Inc. Hao Hong Fortnightly Chinese Takeaway: The China Syndrome 6 $30 View Abstract
20-Mar-09 Brean Murray & Co., Inc. Eric M. Beder, Hao Hong, Jose Haresco Morning Insight (AMMD, JCG, SHFL, Fortnightly Chinese Takeaway) 7 $30 View Abstract

Independent Reports (Showing 1 to 10 of 27)

Release
Date Contributor Author Title Pages Price More Info
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR 5 $25 View Abstract
17-Nov-09 Institutional Shareholder Services N/A ISS Report on China Medical Technologies Inc. 9 $100 View Abstract
16-Nov-09 Institutional Shareholder Services N/A ISS Report on China Medical Technologies Inc. 8 $100 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR 5 $25 View Abstract
8-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR 5 $25 View Abstract
8-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR 5 $25 View Abstract
5-Nov-09 Global Markets Direct Global Markets Direct China Medical Technologies, Inc. - medical equipment - Deals and Alliances Profile 37 $250 View Abstract
4-Nov-09 Global Markets Direct Global Markets Direct China Medical Technologies, Inc. Financial Analysis Review 34 $300 View Abstract
2-Nov-09 Graham & Whiteside Limited Graham & Whiteside PEOPLE'S REPUBLIC OF CHINA - Public BIOTECHNOLOGY Companies - Graham & Whiteside listing 9 $100 View Abstract
2-Nov-09 Graham & Whiteside Limited Graham & Whiteside PEOPLE'S REPUBLIC OF CHINA - Public PHARMACEUTICALS Companies - Graham & Whiteside listing 30 $200 View Abstract
Next 17

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.